Sjögren-larsson syndrome Q87.13

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 28.01.2022

Dieser Artikel auf Deutsch

Synonym(s)

Ichthyosis congenita with oligophrenia and spastic di/tetraplegia; Oligophrenia-Ithyosis-Syndrome; OMIM 270200

History
This section has been translated automatically.

Larsson and Sjögren, 1957

Definition
This section has been translated automatically.

Autosomal recessive, rare, syndromal ichthyosis with combination of oligophrenia, ichthyosis, central coordination disorder usually in the form of spastic di-, rarely tetraplegia.

Etiopathogenesis
This section has been translated automatically.

Autosomal recessive mutations of the ALDH3A2 gene(aldehyde dehydrogenase 3 A2 gene; gene locus: 17p11.2) with consecutive reduction in activity of the fatty alcohol NAD+ oxidoreductase complex(FALDH), especially dehydrogenase. This results in an increase of fatty alcohols and fatty aldehydes in plasma.

Clinical features
This section has been translated automatically.

Skin changes corresponding to ichthyosis congenita, hypohidrosis, di- or tetraplegia, short stature, oligophrenia, skeletal, dental and retinal changes can occur.

Variable clinic with oligophrenia, generalized ichthyosis (up to the development of erythroderma), progressive cerebral tonus and movement disorders (diplegia, tetraplegia) and speech disorders. In individual cases eye fundus anomalies, especially retinitis pigmentosa and macular degeneration as well as glistening spots.

Further associations are thoracic kyphosis, epilepsy or oligoepilepsy, gingivitis and periodontitis, enamel defects, degenerative stigmas like hypertelorism or epicanthus.

Diagnosis
This section has been translated automatically.

Clinical presentation with syndromal symptoms; molecular genetic diagnosis with wet detection of the mutation.

Differential diagnosis
This section has been translated automatically.

General therapy
This section has been translated automatically.

Diets with medium-chain fatty acids can lead to an improvement of the skin condition.

External therapy
This section has been translated automatically.

According to the ichthyoses (see below Ichthyosis vulgaris, autosomal dominant).

Internal therapy
This section has been translated automatically.

Systemic therapy with Acitretin (Neotigason).

Progression/forecast
This section has been translated automatically.

Progressive course, reduced life expectancy.

Literature
This section has been translated automatically.

  1. Akdeniz N et al (2003) Report of a Turkish child with Sjoren-Larsson syndrome associated with peripheral nerve involvement. J Dermatol 30: 222-225
  2. Blanchet-Bardon CB et al (1991) Acitretin in the treatment of severe disorders of keratinization. J Am Acad Dermatol 24: 982-86.
  3. DiGiovanna JJ et al (2003) Ichthyosis: etiology, diagnosis, and management. Am J Clin Dermatol 4: 81-95.
  4. Kelson TL et al (1992) Carrier detection for Sjögren-Larsson syndrome: J Inherit Metab Dis 15(1): 105-111.
  5. Mohrenschlager M et al (2000) Sjogren-Larsson syndrome. Dermatologist 51: 250-255
  6. Scalais E et al (1992) Sjögren-Larsson-like syndrome with bone dysplasia and normal fatty alcohol N-oxidoreductase activity. Pediatr Neurol 8: 459-465
  7. Sjögren T, Larsson T (1957) Oligophrenia in combination with congenital ichthyosis and spastic disorders. A clinical and genetic study. Acta psychiat neurol scand 32(Suppl113): 9-105.
  8. Tabsh K et al (1993) Sjögren-Larsson syndrome: technique and timing of prenatal diagnosis. Obstet Gynecol 82 (Suppl): 700-703
  9. Theile U (1974) Sjögren-Larsson syndrome. Oligophrenia-ichthyosis-di-/tetraplegia. Human Genetics 22: 91-118

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 28.01.2022